Pregnancy and Birth

Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.

Women with class 3 obesity before becoming pregnant have up to a 4.5-fold greater risk of composite maternal morbidity that includes preeclampsia, preterm delivery, DM.

Your daily dose of the clinical news you may have missed.

Women referred from obstetrics to primary care postpartum via a pilot program were more likely to attend a PCP visit than nonreferred women.

Your daily dose of the clinical news you may have missed.

More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.

An overview of safe treatment options for migraine attacks that may occur during pregnancy for primary care clinicians, here.

First nonprescription daily oral contraceptive pill, OTC opioid antagonist nasal spray for opioid overdose, and 5 more FDA-approved drugs primary care clinicians should know about.

Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.

The FDA approved Abrysvo for use in pregnant individuals to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.

The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.

The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.

Opill, a progestin-only oral contraceptive, if approved by the FDA, would be the first an only form of birth control in the US available without a physician's prescription.

Women with prior HC-associated depression had a higher risk of developing a depressive episode during pregnancy and postpartum than women with non-HC-associated depression.

Your daily dose of clinical news you may have missed.

Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.

ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.

Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.

Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.

Black women seeking fertility care were less likely to report getting COVID-19 vaccine and were unsatisfied with how major health care systems handled the pandemic.

Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.

Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.

ACC 2022: Use of antihypertensive therapy in pregnant women was associated with better pregnancy outcomes, such as preeclampsia and fetal or neonatal death.